Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 106   

Articles published

SHP 3,551.48 -119.52 (-3.26%)
price chart
Shire PLC (SHP) Rating Reiterated by AlphaValue
Shire PLC logo Shire PLC (LON:SHP)'s stock had its “buy” rating reissued by analysts at AlphaValue in a report released on Thursday, Analyst Ratings.
Shire PLC (SHP) Given Overweight Rating at JPMorgan Chase & Co.  Intercooler Financial
Were Analysts Bullish Shire PLC (LON:SHP) This Week?  Sonoran Weekly Review
Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC
Shares in GlaxoSmithKline (LSE: GSK) were given a boost this week when it reported better-than-expected quarterly results. Furthermore, it announced that its transformation programme is on track and that the company in on target to deliver �3bn in ...
Shire PLC (SHPG) Price Target Cut to $220.00 by Analysts at Susquehanna
Shire PLC logo Shire PLC (NASDAQ:SHPG) had its target price decreased by Susquehanna from $280.00 to $220.00 in a research note issued to investors on Monday, StockTargetPrices.
Price Target Update On Shire Plc (NASDAQ:SHPG)  Risers & Fallers
Shire plc (NASDAQ:SHPG) Analyst Ratings and Target Update  Uptick Analyst
Shire plc (SHPG) to Acquire Baxalta (BXLT) in ~$32B Deal
Shire plc (NASDAQ: SHPG) and Baxalta Incorporated (NYSE: BXLT) today announced that the boards of directors of both companies have reached an agreement under which Shire will combine with Baxalta.
Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit  Reuters
Shire PLC Spends $32 Billion on Baxalta Inc. -- An Arbitrage Opportunity?  Motley Fool
Why Now Is The Time To Buy HSBC Holdings plc, Shire Plc And Rolls-Royce ...
Long-term investors should be viewing the market sell-off since the New Year as an opportunity to snap up shares of well-run companies that have been unfairly dented by broader market panic.
Shire PLC (SHP) Earns Buy Rating from Jefferies Group  Intercooler Financial
Is Now The Time To Buy Shire PLC, SkyePharma PLC And Indivior PLC?
Is there value in small and mid-sized pharmaceutical companies? Three popular choices with solid profits are Shire (LSE: SHP), SkyePharma (LSE: SKP) and Indivior (LSE: INDV).
Are Healthcare Superstars Shire PLC, AstraZeneca plc and GlaxoSmithKline plc ...
The pharmaceutical sector has been one of the best performing sectors in the last few years. A global M&A surge has rippled through the sector, especially in the USA, and has sent stock prices surging.
Moody's assigns Baa3 issuer rating to Shire plc; stable outlook
Headquartered in Dublin, Ireland and domiciled in Jersey (Channel Islands), Shire plc ("Shire") is a global biopharmaceutical company with expertise in rare diseases, neuroscience and gastroenterology.
S&P Starts Shire plc (SHPG) at 'BBB-'; Outlook Stable  StreetInsider.com
Shire plc Assigned Investment Grade Credit Ratings by Moody's and S&P  PR Newswire (press release)
Analysts At UBS Reiterated Shire Plc (LON:SHP) As Buy
Today analysts at UBS reiterated Shire Plc's (LON:SHP) shares as 'Buy' in a report released to investors. According to UBSs price target of 5200 on the company's stock this indicates the broker now believes there is an increase of 38.41% from Shire Plc ...
Sanford C. Bernstein Reiterates "Outperform" Rating for Shire PLC ...  Financial Market News
JP Morgan Cazenove Maintained Shire PLC (LON:SHP)'s “Overweight” Rating  WallStreet.org
Shire PLC (SHPG) - Investment Analysts' Recent Ratings Changes
1/18/2016 - Shire PLC was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating. 1/15/2016 - Shire PLC was upgraded by analysts at Bank of America from a “neutral” rating to a “buy” rating. 1/13/2016 - Shire PLC had its ...
Shire PLC (ADR) (NASDAQ:SHPG) close to 52-week low, short interest dropping  Street Report
Shire Plc (LON:SHP) Receives Buy Rating From UBS Analysts  Risers & Fallers